## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancerβspecific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with shortβcourse androgen suppression therapy (RT+AST) or radica
Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy
β Scribed by Ogawa, Osamu ;Iinuma, Masanori ;Sato, Kazunari ;Sasaki, Ryusei ;Shimoda, Naotake ;Satoh, Shigeru ;Kato, Tetsuro
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 186 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could
## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative longβterm efficacy of radical prostatectomy (RP) versus conventionalβdose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A